Loading…

Novus International completed its acquisition of US enzyme producer BioResource International, gaining ownership of its products, intellectual property and facilities. BRI makes protease, xylanase, mannanase and phytase feed enzymes, and Novus has manufactured its protease product with BRI since 2008.
The deal is a corporate ownership change in feed enzymes with no clear effect on grain, oilseed or protein supply or prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.